Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 May 18.
Published in final edited form as: J Invest Dermatol. 2015 Nov 18;136(2):533–535. doi: 10.1016/j.jid.2015.11.002

Distinct histologic subtypes and risk factors for early onset basal cell carcinoma: A population-based case control study from New Hampshire

Dorothea T Barton 1,2, Michael S Zens 3, Heather H Nelson 4, Brock C Christensen 3,5, Craig A Storm 2, Ann E Perry 2, Margaret R Karagas 3
PMCID: PMC4790460  NIHMSID: NIHMS734858  PMID: 26967485

To the Editor

Basal cell carcinoma (BCC) is the most prevalent cancer diagnosed in the United States. A subset of BCC behave more aggressively and are associated with a higher risk of recurrence, local tissue destruction, deeper invasion, subclinical spread, morbidity and local and distant metastasis risk (Walling et al., 2004). An important indicator of potential for aggressive clinical behavior is the histologic subtype of BCC. Aggressive histologic subtypes include infiltrative, sclerosing, morpheaform, basosquamous and micronodular types, which often require more vigorous therapeutic regimens (Batra and Kelley, 2002; Blixt et al., 2013). The increase in incidence rates of BCC among younger individuals, particularly women, has spurred renewed interest in early onset BCC (Arits et al., 2011; Christenson et al., 2005; Karagas et al., 2014).

We examined tumor characteristics and risk factors in the New Hampshire Skin Cancer Study, a population-based case–control study of keratinocyte cancers. Cases were identified through comprehensive surveillance of dermatology and dermatopathology practices along with pathology laboratories in New Hampshire. Controls were randomly selected from lists of state residents provided by the New Hampshire Department of Transportation (individuals < 65 years old) and the Center for Medicaid and Medicare services (individuals ≥ 65 years old) (Karagas et al., 1999; Karagas et al., 2002; Karagas et al., 2010; Karagas et al., 2007). Early onset cases were diagnosed with BCC between 24 and 49 years of age, while late onset cases were diagnosed at ≥50 years of age. Of the 1,823 cases and 2,062 controls confirmed eligible, 1,578 (86.6%) cases and 1497 (72.6%) controls were interviewed. Odds ratios (OR) were calculated using unconditional logistic regression, controlling for potentially confounding effects of age, gender, and study phase. Modifying effects were calculated on subjects stratified by gender, study phase, anatomic site, sun exposure (sun sensitivity to first solar exposure, number of painful sunburns in childhood, recreational sun exposure) and subject characteristics including family history of melanoma, number of nevi, hair color, eye color, skin color, freckling and ethnicity. Subgroup analyses were used to evaluate associations of molecular or histologic subtypes and disease onset. Statistical analyses were conducted using SAS version 9.4 (SAS Institute, Inc, Cary, NC) ((Karagas et al., 2014; Torti et al., 2011); details are provided in Supplemental data). A board-certified dermatopathologist (A.E.P.) confirmed histologic subtype (including aggressive subtypes: infiltrative, sclerosing, morpheaform and micronodular) (Batra and Kelley, 2002; Sexton et al., 1990; Walling et al., 2004), presence of actinic keratoses and severity of solar elastosis. Basosquamous and metatypical subtypes were excluded to avoid confounding with basaloid SCCs and inadvertently misclassified SCCs (Webb et al., 2015). Molecular analyses for PTCH and TP53 were performed as described (Danaee et al., 2006; Louhelainen et al., 1998; Torti et al., 2011); also see Supplemental data.

Of 1,578 newly-diagnosed cases of BCC, 674 were early onset (≤50 years) and 904 were later onset (> 50 years) at diagnosis. These were compared to 460 controls ≤ 50 years and 1,010 controls >50 years. Mean age at diagnosis was 43.3 ± 5.5 years and 64.0 ± 6.7 years for early versus late onset BCC, respectively. Demographics and tumor characteristics are compared in Table 1. Patients with early onset BCC were more likely to be women (61.6% versus 41.3%; OR 2.2, 95% CI 1.7–2.7) and exhibit an aggressive histological subtype (7.6% of early onset cases versus 2.1% of late onset cases (OR 3.9, 95% CI 1.9–8.0). Anatomical localization differed, with a higher percentage of early onset BCC tumors localized on the head or neck (93.3% vs 83.6%; OR 2.8 95% CI 1.9–4.2). The frequency of genetic alterations in PTCH and TP53 were not different (Supplemental Table 1).

Table 1.

Case-case comparison of demographic and tumor characteristics of early onset basal cell carcinoma (BCC) compared to later onset BCC.

Variable Early onset
(≤50 years old) N (%)
Late onset
(> 50 years old) N (%)
OR (95% CI)1
Gender male 259 (38.4) 540 (59.7) 1.0 (ref)
female 415 (61.6) 364 (40.3) 2.2 (1.7–2.7)
Histologic subtype2 nonaggressive BCC 463 (92.4) 467 (97.9) 1.0 (ref)
aggressive BCC 38 (7.6) 10 (2.1) 3.9 (1.9–8.0)
Solar elastosis low/moderate 42 (40.4) 65 (25.0) 1.0 (ref)
severe 62 (59.6) 195 (75.0) 0.5 (0.3–0.8)
Anatomic Site trunk 33 (5.0) 110 (12.5) 1.0 (ref)
lower limbs 5 (0.8) 14 (1.6) 1.1 (0.4–3.3)
upper limbs 6 (0.9) 20 (2.3) 1.2 (0.4–3.2)
head or neck 611 (93.3) 734 (83.6) 2.8 (1.9–4.2)
1

Odd ratios and 95% confidence intervals were estimated by logistic regression and adjusted by study phase and gender (male, female).

2

Tumor morphology was reviewed by a single pathologist in phase 2 and phase 3 of the study on the 978 subjects whose tumor material was available. The aggressive histology types are 8092.1/3 8092.2/3 8092.3/3.

We also compared known BCC risk factors (Table 2). Risk factors linked to sun exposure including skin sensitivity to first solar exposure, number of painful sunburns in childhood, number of blistering sunburns in childhood and recreational sun exposure, were associated with both early and late onset BCC. However, the strength of associations for sun sensitivity to first solar exposure and number of blistering sunburns in childhood was approximately twice as strong in the early onset BCC cases. Other risk factors were similar (Supplemental Table 2).

Table 2.

Risk factors for early and late onset basal cell carcinoma (BCC) compared to controls.

Early onset (≤ 50 years old) Late Onset (> 50 years old)
Variable Controls Cases OR (95% CI)a Controls Cases OR (95% CI)1
N (%) N (%) N (%) N (%)
Sun sensitivity to first solar exposure2
  tan 59 (12.9) 26 (3.9) 1.0 (ref) 196 (19.6) 88 (9.8) 1.0 (ref)
  mild burn then tan 218 (47.7) 290 (43.5) 3.0 (1.8–4.9) 505 (50.6) 437 (48.8) 1.9 (1.4–2.6)
  burn then peel 154 (33.7) 301 (45.2) 4.4 (2.6–7.2) 231 (23.1) 306 (34.2) 2.9 (2.1–3.9)
  burn then blister 26 (5.7) 49 (7.4) 4.2 (2.1–8.1) 67 (6.7) 64 (7.2) 2.1 (1.4–3.2)
Number of painful sunburns in childhood3
  None 203 (47.1) 218 (36.0) 1.0 (ref) 507 (55.5) 393 (45.7) 1.0 (ref)
  1–3 79 (18.3) 77 (12.7) 0.9 (0.6–1.3) 168 (1 8.4) 139 (16.2) 1.0 (0.8–1.3)
  4–9 74 (17.2) 121 (20.0) 1.5 (1.1–2.2) 162 (17.7) 183 (21.3) 1.4 (1.1–1.8)
≥ 10 75 (17.4) 190 (31.4) 2.5 (1.8–3.5) 76 (8.3) 145 (16.9) 2.6 (1.9–3.5)
ptrend < 0.0001 ptrend < 0.0001
Number of blistering sunburns in childhood4
  None 345(79.9) 407(66.9) 1.0 (ref) 722(78.8) 593(69.0) 1.0 (ref)
  1 49(11.3) 74(12.2) 1.3(0.9–1.9) 84(9.2) 102(11.9) 1.4(1.1–2.0)
  2–6 14(3.2) 35(5.8) 2.1(1.1–4.0) 39(4.3) 68(7.9) 2.0(1.4–3.1)
≥ 7 24(5.6) 92(15.1) 3.3(2.0–5.2) 71(7.8) 96(11.2) 1.7(1.2–2.3)
ptrend < 0.0001 ptrend < 0.013
Recreational sun exposure – proportion of lifetime5
< 0.495 52 (12.1) 86 (14.3) 1.0 (ref) 278 (31.3) 213 (25.3) 1.0 (ref)
  0.495 to < 0.673 99 (23.0) 115 (19.1) 0.7 (0.5–1.1) 228 (25.7) 197 (23.4) 1.1 (0.8–1.4)
  0.673 to < 0.844 144 (33.5) 185 (30.7) 0.8 (0.5–1.2) 186 (21.0) 200 (23.8) 1.4 (1.1–1.8)
≥ 0.844 135 (31.4) 217 (36.0) 1.0 (0.6–1.5) 195 (22.0) 231 (27.5) 1.6 (1.2–2.1)
ptrend < 0.0164 ptrend < 0.0011
1

Odd ratios and 95% confidence intervals were estimated by logistic regression and adjusted by study phase, age at diagnosis and gender (male, female).

2

In sun sensitivity to first solar exposure, 11 controls and 9 cases are missing in late onset BCC; 3 controls and 8 cases missing from early onset BCC. These same subjects were missing in all other exposure variables.

3

The number of painful sunburns in child hood was missing in 126 controls and 112 cases.

4

The number of blistering sunburns in childhood was missing in 129 controls and 118 cases.

5

Recreational sun exposure was missing in 153 controls and 134 cases.

Overall, early onset BCC was more frequently associated with aggressive histologic BCC subtypes (infiltrative, sclerosing, morpheaform and micronodular), occurred more commonly on the head and neck, and among women. In addition, risk factors such as sensitivity to first solar exposure and number of blistering sunburns in childhood, appeared to increase susceptibility to early onset BCC to a greater extent than late onset BCC, suggesting there may be an interplay between inherent susceptibility and environmental exposure in early onset BCC. We did not find a corresponding increase in mutations or LOH affecting the tumor suppressors p53 or PTCH in early onset BCC, which have been reported in sporadic BCCs and in some small studies of early onset BCCs (Zhang et al., 2001). Additional data are needed to define the molecular landscape of this disease.

Our study has limitations. The average age of individuals who we defined as early onset BCC was approximately 43 years. Although this is approximately 20 years younger than our late onset cases, it is older than the average age of early onset BCC used in several previous studies (Christenson et al., 2005; Ferrucci et al., 2012). Nevertheless, our ability to identify meaningful differences between these two populations suggests that this is a reasonable cut point.

One hypothesis for the increasing incidence rates of early onset BCC has been increased awareness and skin surveillance. However, lesion size has not decreased over time, as might be anticipated if earlier detection were the underlying cause of increased incidence (Christenson et al., 2005). Our results likewise suggest that early onset BCC is associated with aggressive histologic characteristics, as opposed to a less aggressive phenotype that might be expected if surveillance bias were operating. Although additional studies are needed, these results suggest there may be underlying biological differences between early and late onset BCC.

Supplementary Material

01

Acknowledgements

The authors thank the study investigators of the New Hampshire Skin Cancer Study Group, the New Hampshire Society of Dermatology, staff of the New Hampshire Health Study, and study participants.

This manuscript was funded in part by R01 CA057494 (DB, MK).

Abbreviations

BCC

Basal Cell Carcinoma

SCC

Squamous Cell Carcinoma

NMSC

Non-melanoma Skin Cancer

Footnotes

The authors state no conflict of interest.

REFERENCES

  1. Arits AH, Schlangen MH, Nelemans PJ, et al. Trends in the incidence of basal cell carcinoma by histopathological subtype. Journal of the European Academy of Dermatology and Venereology : JEADV. 2011;25:565–569. doi: 10.1111/j.1468-3083.2010.03839.x. [DOI] [PubMed] [Google Scholar]
  2. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Archives of dermatology. 2002;138:1043–1051. doi: 10.1001/archderm.138.8.1043. [DOI] [PubMed] [Google Scholar]
  3. Blixt E, Nelsen D, Stratman E. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al] 2013;39:719–725. doi: 10.1111/dsu.12122. [DOI] [PubMed] [Google Scholar]
  4. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. Jama. 2005;294:681–690. doi: 10.1001/jama.294.6.681. [DOI] [PubMed] [Google Scholar]
  5. Danaee H, Karagas MR, Kelsey KT, et al. Allelic loss at Drosophila patched gene is highly prevalent in Basal and squamous cell carcinomas of the skin. The Journal of investigative dermatology. 2006;126:1152–1158. doi: 10.1038/sj.jid.5700209. [DOI] [PubMed] [Google Scholar]
  6. Ferrucci LM, Cartmel B, Molinaro AM, et al. Host phenotype characteristics and MC1R in relation to early-onset basal cell carcinoma. The Journal of investigative dermatology. 2012;132:1272–1279. doi: 10.1038/jid.2011.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Karagas MR, Greenberg ER, Spencer SK, et al. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. International journal of cancer Journal international du cancer. 1999;81:555–559. doi: 10.1002/(sici)1097-0215(19990517)81:4<555::aid-ijc9>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  8. Karagas MR, Stannard VA, Mott LA, et al. Use of tanning devices and risk of basal cell and squamous cell skin cancers. Journal of the National Cancer Institute. 2002;94:224–226. doi: 10.1093/jnci/94.3.224. [DOI] [PubMed] [Google Scholar]
  9. Karagas MR, Waterboer T, Li Z, et al. Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study. Bmj. 2010;341:c2986. doi: 10.1136/bmj.c2986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Karagas MR, Zens MS, Li Z, et al. Early-onset basal cell carcinoma and indoor tanning: a population-based study. Pediatrics. 2014;134:e4–e12. doi: 10.1542/peds.2013-3559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Karagas MR, Zens MS, Nelson HH, et al. Measures of cumulative exposure from a standardized sun exposure history questionnaire: a comparison with histologic assessment of solar skin damage. American journal of epidemiology. 2007;165:719–726. doi: 10.1093/aje/kwk055. [DOI] [PubMed] [Google Scholar]
  12. Louhelainen J, Lindstrom E, Hemminki K, et al. Dinucleotide repeat polymorphism within the tumor suppressor gene PTCH at 9q22. Clinical genetics. 1998;54:239–241. doi: 10.1111/j.1399-0004.1998.tb04292.x. [DOI] [PubMed] [Google Scholar]
  13. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. Journal of the American Academy of Dermatology. 1990;23:1118–1126. doi: 10.1016/0190-9622(90)70344-h. [DOI] [PubMed] [Google Scholar]
  14. Torti DC, Christensen BC, Storm CA, et al. Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study. Journal of the American Academy of Dermatology. 2011;65:304–312. doi: 10.1016/j.jaad.2010.05.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Walling HW, Fosko SW, Geraminejad PA, et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer metastasis reviews. 2004;23:389–402. doi: 10.1023/B:CANC.0000031775.04618.30. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

RESOURCES